Efficacy and safety of high-dose inhaled steroids in children with asthma: A comparison of fluticasone propionate with budesonide

Journal of Pediatrics

Volumn 134, Issue 4, 1999, Pages 422-427

  Ferguson, Alexander C ^a,b,c,d,e,f   Spier, Sheldon ^a,b,c,d,e   Manjra, Ahmed ^a,b,c,d,e   Versteegh, Florens G A ^a,b,c,d,e   Mark, Stephen ^a,b,c,d,e   Zhang, Paul ^a,b,c,d,e  

^a BC CHILDREN S HOSPITAL   (Canada)

^b ALBERTA CHILDREN'S HOSPITAL   (Canada)

^c Westville Hospital   (South Africa)

^d GROENE HART HOSPITAL   (Netherlands)

^e GLAXOSMITHKLINE   (United Kingdom)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; FLUNISOLIDE; FLUTICASONE PROPIONATE; HYDROCORTISONE; SALBUTAMOL; TRIAMCINOLONE;

ARTICLE; ASTHMA; CHILD; CHILD GROWTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SORE THROAT; TREATMENT OUTCOME;

EID: 0033506449     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70198-8     Document Type: Article

References (15)

1. 1. The British Guidelines on Asthma Management. Thorax 1997;52(suppl): S1-S21.
2. 2. Fuller R, Johnson M, Bye A. Fluticasone propionate: an update on preclinical and clinical experience. Respir Med 1995;89:3-18.
3. 3. Gustafsson P, Tsanakas J, Gold M, Primhak R, Radford M, Gillies E. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma. Arch Dis Child 1993;69:206-11.
4. 4. Barnes NC, Hollett C, Harris TA. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less. Respir Med 1998;92:95-104.
5. 5. Langdon CG, Thompson J. A multicentre study to compare the efficacy and safety of inhaled fluricasone propionate and budesonide via metered dose inhalers with mild to moderate asthma. Br J Clin Res 1994;5:73-84.
6. 6. Langdon CG, Capsey LJ. Fluticasone propionate and budesonide in adult asthmatics: a comparison using dry powder inhaler devices. Br J Clin Res 1994;5:85-99.
7. 7. Ayres JG, Bateman ED, Lundback B, Harris TAJ. High dose fluticasone propionate 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily in patients with chronic severe asthma. Eur Respir J 1995;8:579-86.
8. -1. Eur Respir J 1996;9:2263-72.
9. 9. Polgar G, Promadhat V. Pulmonary function testing in children. Techniques and standards. Philadelphia: WB Saunders Co, 1971.
10. 10. Thorsson L, Dahlstrom K, Edsbacker S, Callen A, Poulson G, Wiren G. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects. Br J Clin Pharmacol 1997;43:155-61.
11. 11. Hogger P, Rohdewald P. Binding kinetics of fluticasone propionate to the human glucocorticoid receptor. Steroids 1994;59:597-602.
12. 12. Lipworth BJ, Clark DJ, McFarlane LC. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children. Thorax 1997;52:686-9.
13. 13. Agertoft L, Pedersen S. Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study. Eur Respir J 1997;10:1507-12.
14. 14. Simons FER, the Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. A comparison of beclomethasone, salmeterol and placebo in children with asthma. N Engl J Med 1997;337:1659-65.
15. 15. Doull OJM, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med 1995;151: 1715-9.